Scarica l'app Stockscreener
13.17
5.78%
0.72
Dopo l'orario di chiusura:
13.25
0.08
+0.61%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ADPT Giù?
Forum
Previsione
Precedente Chiudi:
$12.45
Aprire:
$13.05
Volume 24 ore:
3.89M
Relative Volume:
1.82
Capitalizzazione di mercato:
$2.03B
Reddito:
$276.98M
Utile/perdita netta:
$-59.46M
Rapporto P/E:
-33.03
EPS:
-0.3987
Flusso di cassa netto:
$-48.95M
1 W Prestazione:
-11.37%
1M Prestazione:
-17.89%
6M Prestazione:
+4.44%
1 anno Prestazione:
+83.68%
Intervallo 1D:
$12.69
$13.28
Intervallo di 1 settimana:
$12.00
$15.16
Portata 52W:
$6.675
$20.76
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
Nome
Adaptive Biotechnologies Corp
Settore
Industria
Telefono
206-659-0067
Indirizzo
1165 EASTLAKE AVE E, SEATTLE, WA
Compare ADPT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
13.17 | 2.03B | 276.98M | -59.46M | -48.95M | -0.3987 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-09-30 | Iniziato | Guggenheim | Buy |
| 2025-06-18 | Iniziato | Craig Hallum | Buy |
| 2025-03-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-01-05 | Iniziato | Scotiabank | Sector Outperform |
| 2022-12-21 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | Iniziato | Credit Suisse | Underperform |
| 2022-06-03 | Iniziato | Piper Sandler | Neutral |
| 2022-02-16 | Reiterato | BTIG Research | Buy |
| 2022-02-16 | Reiterato | BofA Securities | Buy |
| 2022-02-16 | Reiterato | Goldman | Neutral |
| 2022-02-16 | Reiterato | JP Morgan | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-03-03 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-06-03 | Iniziato | Goldman | Buy |
| 2019-07-23 | Iniziato | BTIG Research | Buy |
| 2019-07-22 | Iniziato | BofA/Merrill | Buy |
| 2019-07-22 | Iniziato | Cowen | Outperform |
| 2019-07-22 | Iniziato | Goldman | Neutral |
| 2019-07-22 | Iniziato | Guggenheim | Buy |
| 2019-07-22 | Iniziato | William Blair | Outperform |
Mostra tutto
Adaptive Biotechnologies Corp Borsa (ADPT) Ultime notizie
Adaptive Biotechnologies CFO Piskel sells $245,910 in shares By Investing.com - Investing.com Nigeria
Insider Sell: Michelle Griffin Sells 15,394 Shares of Adaptive B - GuruFocus
Francis Lo Sells 30,593 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 470,266 Shares - MarketBeat
Adaptive Biotechnologies’ president Rubinstein sells $2.37 million in ADPT stock - Investing.com
Adaptive Biotechnologies director Griffin sells $214,130 in stock - Investing.com
Adaptive Biotechnologies CCO Bobulsky sells $544k in ADPT stock By Investing.com - Investing.com Canada
Adaptive Biotechnologies Executives Sell Shares to Cover Tax Obligations - TradingView
Adaptive Biotechnologies’ chief commercial officer sells $831k in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies CFO Piskel sells $245,910 in shares - Investing.com
Adaptive Biotechnologies’ chief people officer Lo sells $430k in stock By Investing.com - Investing.com South Africa
Adaptive Biotechnologies’ chief commercial officer sells $831k in stock - Investing.com
Adaptive Biotechnologies’ chief scientific officer sells $6.19 million in stock - Investing.com
Adaptive Biotechnologies CEO Robins sells $6.19 million in ADPT stock - Investing.com
Adaptive Biotechnologies’ chief people officer Lo sells $430k in stock - Investing.com UK
Adaptive Biotechnologies Executives Sell Shares for Tax Obligations - TradingView
Adaptive Biotechnologies Hits Day Low of $12 Amid Price Pressure - Markets Mojo
Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap UpWhat's Next? - MarketBeat
Tax-driven share sale by Adaptive Biotechnologies (ADPT) Chief Scientific Officer - Stock Titan
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Price Down 9.9%Here's Why - MarketBeat
Michelle Griffin sells 48,044 ADPT shares (ADPT) for $735K - Stock Titan
Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight By Investing.com - Investing.com India
Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 19,460 Shares of Stock - MarketBeat
Adaptive Biotechnologies Executive Sells Over $1.2 Million in Company Stock - TradingView
[144] Adaptive Biotechnologies Corp SEC Filing - Stock Titan
Piper Sandler reiterates Adeptus Biotechnologies stock rating at overweight - Investing.com
Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT By Investing.com - Investing.com South Africa
Lo Francis, chief people officer at Adaptive Biotechnologies, sells $574k in ADPT - Investing.com Nigeria
Adaptive Biotechnologies (ADPT) HR chief offloads shares to cover RSU taxes - Stock Titan
Do Insider Sales Align With Adaptive Biotechnologies' (ADPT) MRD-Driven Momentum and Long-Term Strategy? - simplywall.st
Adaptive Biotechnologies (NASDAQ:ADPT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Director at Adaptive Biotechnologies (ADPT) receives 15,625-share award - Stock Titan
Adaptive Biotechnologies (ADPT) CCO Benzeno receives 39,063-share stock award - Stock Titan
Adaptive Biotechnologies (ADPT) CSO awarded two large stock grants - Stock Titan
Director Michelle Renee Griffin receives 15,625 ADPT shares in stock grant - Stock Titan
Loss Report: Will Adaptive Biotechnologies Corporation stock go up in YEAR - baoquankhu1.vn
Insider Sales Put Focus On Adaptive Biotechnologies Growth Story And Dilution Risk - Yahoo Finance
Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares By Investing.com - Investing.com UK
Adaptive Biotechnologies’ Rubinstein sells $1.49m in shares - Investing.com Nigeria
Adaptive Biotechnologies (NASDAQ: ADPT) director sells 48,044 shares - Stock Titan
Adaptive Biotechnologies Corp. Achieves 102.46% Yearly Gain, Establishing It as a Multibagger Stock - Markets Mojo
Amova Asset Management Americas Inc. Decreases Stake in Adaptive Biotechnologies Corporation $ADPT - MarketBeat
Insider Sell: Harlan Robins Sells 24,233 Shares of Adaptive Biot - GuruFocus
Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 10,000 Shares - MarketBeat
Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock By Investing.com - Investing.com Australia
Adaptive Biotechnologies CSO Robins sells $392,329 in ADPT stock - Investing.com
Chad Robins Sells 289,024 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock - MarketBeat
Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $823,848.16 in Stock - MarketBeat
Insider Sell: Chad Robins Sells 524,998 Shares of Adaptive Biote - GuruFocus
CEO of Adaptive Biotechnologies (NASDAQ: ADPT) sells 524,998 shares - Stock Titan
Adaptive Biotechnologies CEO Sells Over $8 Million in Company Stock - TradingView
Adaptive Biotechnologies Corp Azioni (ADPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):